Mitsubishi Tanabe Pharma America Announces Presentations at the 30th World Congress on Parkinson's Disease and Related Disorders (IAPRD)

Mitsubishi Tanabe Pharma America Announces Presentations at the 30th World Congress on Parkinson's Disease and Related Disorders (IAPRD)

JERSEY CITY, N.J., May 7, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that two poster presentations on investigational ND0612 in Parkinson's disease (PD) will be shared at the 30th World Congress on Parkinson's Disease and Related…

Explores the network pharmacology and molecular docking-based prediction of the molecular target and signaling pathways of Piperine in the treatment of Parkinson's disease

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease. Piper nigrum, a traditional Chinese medicine, has been commercially successful in treating PD. However, the underlying processes and therapeutic efficacy of Piper nigrum in PD remain unknown. A n...